CIK 0000313143
- Large accelerated filer
HAEMONETICS CORP
Sign in to watch- Ticker
- HAE
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 3
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 042882273
- Phone
- +1 781-848-7100
- Business address
- 125 SUMMER STREET, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $101,148
- in 1 filing
Net −$101,148. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-27 | KROLL MARK W Director | Grant or award | +4,329 | $39.27 | $170K | 26,763 |
| 2017-07-27 | MEELIA RICHARD J Director | Grant or award | +4,329 | $39.27 | $170K | 26,911 |
| 2017-07-19 | Goldstein Dan VP, Corporate Controller | Sale | −197 | $40.39 | $8K | 4,002 |
| 2017-06-29 | Simon, Christopher President & CEO | Sale | −3,595 | $40.39 | $145K | 128,845 |
| 2017-06-06 | Goldstein Dan Chief Accounting Officer | Grant or award | +1,080 | 4,827 | ||
| 2017-06-06 | Goldstein Dan Chief Accounting Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +4,426 | $41.64 | $184K | 4,426 |
| 2017-06-06 | Simon, Christopher President & CEO | Grant or award | +25,516 | $41.64 | $1.1M | 131,383 |
| 2017-06-06 | Simon, Christopher President & CEO | Grant or award · Non-qualified Stock Option (Right to Buy) | +104,516 | $41.64 | $4.4M | 104,516 |
| 2017-06-06 | Burke Willaim P EVP, Chief Financial Officer | Grant or award | +5,583 | $41.64 | $232K | 15,996 |
| 2017-06-06 | Burke Willaim P EVP, Chief Financial Officer | Grant or award · Non-qualified Stock Option (Right to Buy) | +22,870 | $41.64 | $952K | 22,870 |
| 2017-06-06 | Basil Michelle L EVP and General Counsel | Grant or award | +6,003 | $41.64 | $250K | 10,882 |
| 2017-06-06 | Basil Michelle L EVP and General Counsel | Grant or award · Non-qualified Stock Option (Right to Buy) | +24,592 | $41.64 | $1.0M | 24,592 |
| 2017-06-06 | Ryding Neil 122-62-507 EVP, Global Manufacturing | Grant or award | +2,401 | $41.64 | $100K | 19,676 |
| 2017-06-06 | Ryding Neil 122-62-507 EVP, Global Manufacturing | Grant or award · Non-qualified Stock Option (Right to Buy) | +9,836 | $41.64 | $410K | 9,836 |
| 2017-05-22 | MERRIMAN RONALD Director | Option exercise | +8,196 | $36.37 | $298K | 26,003 |
| 2017-05-22 | MERRIMAN RONALD Director | Sale | −8,196 | $40.32 | $330K | 17,807 |
| 2017-05-22 | MERRIMAN RONALD Director | Option exercise · Non-qualified Stock Option (Right to Buy) | −8,196 | 0 | ||
| 2017-05-22 | MERRIMAN RONALD Director | Option exercise | +7,118 | $34.41 | $245K | 24,925 |
| 2017-05-22 | MERRIMAN RONALD Director | Sale | −7,118 | $40.31 | $287K | 17,807 |
| 2017-05-22 | MERRIMAN RONALD Director | Option exercise | +10,353 | $30.50 | $316K | 28,160 |
Page 42 of 47 · 929 trades